|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.257
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.192
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.180
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.179
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.149
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.144
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.136
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.127
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.123
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.123
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.104
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.104
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.101
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.092
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.088
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.086
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.085
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.084
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.084
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.083
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.083
|
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.082
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.080
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.080
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.079
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.077
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.074
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.073
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.072
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.072
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.070
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.068
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.068
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.067
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.067
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.067
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.066
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.066
|
|
|
|
vegf activated neuropilin signaling pathway
|
GO:0038190 |
2 |
0.063
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.063
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.062
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.062
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.061
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.060
|
|
|
|
phospholipid biosynthetic process
|
GO:0008654 |
36 |
0.059
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.059
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.059
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.059
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.059
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.059
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.057
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.057
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.057
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.056
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.056
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.056
|
|
|
|
response to x ray
|
GO:0010165 |
11 |
0.055
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.055
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.054
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.054
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.054
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.054
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.054
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.054
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.054
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.054
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.053
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.053
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.053
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.053
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.053
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.052
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.052
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.051
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.051
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.051
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.051
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.050
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.050
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.050
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.050
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.050
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.050
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.050
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.049
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.049
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.049
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.049
|
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.048
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.048
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.048
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.048
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.047
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.047
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.047
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.047
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.047
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.047
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.047
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.046
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.046
|
Human |
|
|
blood coagulation
|
GO:0007596 |
76 |
0.046
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.046
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.046
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.046
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.046
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.045
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.045
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.045
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.044
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.044
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.044
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.044
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.043
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.043
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.043
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.043
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.043
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.042
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.042
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.042
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.042
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.041
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.041
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.041
|
|
|
|
protein o linked glycosylation
|
GO:0006493 |
16 |
0.040
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.040
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.040
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.040
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.040
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.040
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.040
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.040
|
|
|
|
neuropilin signaling pathway
|
GO:0038189 |
2 |
0.039
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.039
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
42 |
0.039
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.038
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.038
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.038
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.038
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.038
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.038
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.038
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.038
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.037
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.037
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.037
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.036
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.036
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.036
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.036
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.036
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.035
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.035
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.035
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.035
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.034
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.034
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.034
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.034
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.034
|
|
|
|
renal system process involved in regulation of blood volume
|
GO:0001977 |
4 |
0.034
|
|
|
|
negative chemotaxis
|
GO:0050919 |
14 |
0.033
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.033
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.033
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.033
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.033
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.033
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.033
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.033
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.033
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.033
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.033
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.032
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.032
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.032
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.032
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.032
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.032
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.032
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.032
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.032
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.032
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.032
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.032
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.031
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.031
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.031
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.031
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.031
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.031
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.031
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.031
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.031
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.031
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.031
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.031
|
Human |
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.030
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.030
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.030
|
|
|
|
cellular response to vascular endothelial growth factor stimulus
|
GO:0035924 |
11 |
0.030
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.030
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.030
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.030
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.030
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.030
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.030
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.030
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.030
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.030
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.030
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.029
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.029
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.029
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.029
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.029
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.029
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.029
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.029
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.029
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.029
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.029
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.029
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.029
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.028
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.028
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.028
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.028
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.028
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.028
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.028
|
|
|
|
paracrine signaling
|
GO:0038001 |
1 |
0.028
|
|
|
|
primitive erythrocyte differentiation
|
GO:0060319 |
3 |
0.028
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.028
|
|
|
|
positive regulation of protein autophosphorylation
|
GO:0031954 |
4 |
0.028
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.028
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.028
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.028
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.028
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.028
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.028
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.028
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.027
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.027
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.027
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.027
|
|
|
|
metanephric glomerular endothelium development
|
GO:0072264 |
1 |
0.027
|
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.027
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.027
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.027
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.027
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.027
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.027
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.027
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.027
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.027
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.027
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.026
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.026
|
|
|
|
lung vasculature development
|
GO:0060426 |
7 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.026
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.026
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.026
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.026
|
|
|
|
cellular response to x ray
|
GO:0071481 |
2 |
0.026
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.026
|
|
|
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.026
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.026
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.026
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.026
|
Human |
|
|
platelet activation
|
GO:0030168 |
40 |
0.026
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.026
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.026
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.025
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.025
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.025
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.025
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.025
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.025
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.025
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.025
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.025
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.025
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.024
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.024
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.024
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.024
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.024
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.024
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.024
|
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.024
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.024
|
|
|
|
chemical homeostasis within a tissue
|
GO:0048875 |
9 |
0.024
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.024
|
|
|
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.023
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.023
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.023
|
|
|
|
positive regulation of retinal ganglion cell axon guidance
|
GO:1902336 |
2 |
0.023
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.023
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.023
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.023
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.023
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.023
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.023
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.023
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.023
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.023
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.022
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.022
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.022
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.022
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.022
|
|
|
|
regulation of glomerular filtration
|
GO:0003093 |
3 |
0.022
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.022
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.022
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.022
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.022
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.022
|
|
|
|
mammary gland lobule development
|
GO:0061377 |
22 |
0.022
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.022
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
18 |
0.022
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.022
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.021
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.021
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.021
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.021
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.021
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.021
|
|
|
|
positive regulation of mitotic cell cycle embryonic
|
GO:0045977 |
2 |
0.021
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.021
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.021
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.021
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.021
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.020
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.020
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.020
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.020
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.020
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.020
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.020
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.020
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.020
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.020
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.020
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.020
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.020
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.020
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.020
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.020
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
41 |
0.020
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.020
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.020
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.020
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.020
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.020
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.020
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.020
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.020
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.020
|
|
|
|
cell differentiation involved in metanephros development
|
GO:0072202 |
12 |
0.020
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.019
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.019
|
|
|
|
lactation
|
GO:0007595 |
25 |
0.019
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.019
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.019
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.019
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.019
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.019
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.019
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.019
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.019
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.019
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.019
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.019
|
|
|
|
cell differentiation involved in kidney development
|
GO:0061005 |
33 |
0.019
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.019
|
|
|
|
positive regulation of glomerular filtration
|
GO:0003104 |
1 |
0.018
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.018
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.018
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.018
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.018
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.018
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.018
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.018
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.018
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.018
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.018
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.018
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.018
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.018
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.018
|
|
|
|
negative regulation of phospholipid biosynthetic process
|
GO:0071072 |
1 |
0.018
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.018
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.018
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.018
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.018
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.017
|
|
|
|
metanephric glomerulus development
|
GO:0072224 |
13 |
0.017
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.017
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.017
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.017
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.017
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.017
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.017
|
|
|
|
platelet derived growth factor receptor beta signaling pathway
|
GO:0035791 |
4 |
0.017
|
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.017
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.017
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.017
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
14 |
0.017
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.017
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.017
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.017
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.017
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.017
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.017
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.017
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.017
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.017
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.017
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.017
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.017
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.017
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.017
|
|
|
|
regulation of retinal ganglion cell axon guidance
|
GO:0090259 |
2 |
0.016
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.016
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.016
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
|
positive regulation of axon extension
|
GO:0045773 |
20 |
0.016
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.016
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.016
|
|
|
|
regulation of branching involved in salivary gland morphogenesis by epithelial mesenchymal signaling
|
GO:0060683 |
1 |
0.016
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.016
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.016
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.016
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
|
positive regulation of lymphangiogenesis
|
GO:1901492 |
3 |
0.016
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.016
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.016
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.016
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.016
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.016
|
Human |
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.016
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.016
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.016
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.016
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.016
|
|
|
|
metanephric mesangial cell differentiation
|
GO:0072209 |
1 |
0.016
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.016
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.015
|
|
|
|
phosphatidylinositol biosynthetic process
|
GO:0006661 |
15 |
0.015
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.015
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.015
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.015
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.015
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.015
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.015
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.015
|
|
